STEMTECH CORPORATION

STEK ·Healthcare, Medical Distribution, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Revenue $2.9M $5.1M $4.9M $4.6M $4.3M $4.4M
Cost of Revenue $566.9K $1.3M $1.0M $1.2M $1.0M $715.2K
Gross Profit $2.3M $3.7M $3.9M $3.4M $3.3M $3.7M
Gross Margin 80.3% 73.8% 79.6% 74.5% 76.3% 83.7%
Operating Expenses
Research & Development $0 $0 $13.8K $0 $750
SG&A Expense $4.6M $5.2M $6.4M $6.8M $4.8M $3.4M
Operating Income $-2.7M $-2.4M $-4.2M $-5.0M $-3.2M $-1.4M
Operating Margin -94.2% -47.2% -85.8% -110.2% -74.3% -32.7%
Interest Expense $8.3M $158.7K
Pretax Income $-4.0M $-3.8M $-5.4M $-8.5M $-7.1M $-1.7M
Income Tax Expense $0 $0 $0 $95.6K $0 $-65
Net Income $-4.0M $-3.8M $-5.4M $-8.5M $-7.1M $-916.7K
Net Margin -140.7% -74.6% -110.3% -187.4% -163.8% -20.9%
EPS (Basic) $-0.02 $-0.03 $-0.07 $-0.19 $-0.20 $-0.03
EPS (Diluted) $-0.02 $-0.03 $-0.07 $-0.19 $-0.20 $-0.03
Shares Outstanding (Basic) 169.8M 118.7M 83.5M 46.0M 35.3M 37.3M
Shares Outstanding (Diluted) 169.8M 118.7M 83.5M 46.0M 35.3M 37.3M
Dividends Per Share